(Q44348671)

2 December 2017

title

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts (English)

1 reference

2 December 2017

0 references

Fudala PJ

1

1 reference

2 December 2017

Yu E

2

1 reference

2 December 2017

Macfadden W

3

1 reference

2 December 2017

Boardman C

4

1 reference

2 December 2017

Chiang CN

5

1 reference

2 December 2017

publication date

1 March 1998

1 reference

Drug and Alcohol Dependence

2 December 2017

published in

1 reference

2 December 2017

volume

50

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

1-8

1 reference

Buprenorphine treatment of opioid dependence: A review

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Buprenorphine abuse: report from India

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland).

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Buprenorphine: a review of its pharmacological properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Liability of addiction to 6-dimethylamino-4-4-diphenyl-3-heptanone (methadon, amidone or 10820) in man; experimental addiction to methadon.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Sublingual versus subcutaneous buprenorphine in opiate abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Therapeutic Usefulness of Propoxyphene Napsylate in Narcotic Addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

1 reference

7 January 2021

Behavioral pharmacology of buprenorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Buprenorphine and naloxone interactions in opiate-dependent volunteers*

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Sublingual buprenorphine as postoperative analgesic: a double-blind comparison with pethidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Methadone-naloxone mixtures for use in methadone maintenance programs. I. An evaluation in man of their pharmacological feasibility. II. Demonstration of acute physical dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Buprenorphine abuse among opiate addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Plasma levels of opioid material in man following sublingual and intravenous administration of buprenorphine: exogenous/endogenous opioid interaction?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Assessment of opioid dependence with naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Subjective and physiologic effects of intravenous buprenorphine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Buprenorphine and naloxone alone and in combination in opioid-dependent humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Effects of sublingually given naloxone in opioid-dependent human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Assessment and management of opioid withdrawal symptoms in buprenorphine‐dependent subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Effects of buprenorphine and methadone in methadone-maintained subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Buprenorphine alone and in combination with naloxone in non-dependent humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

Acute physical dependence in humans: repeated naloxone-precipitated withdrawal after a single dose of methadone

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900008-8

7 January 2021

10.1016/S0376-8716(98)00008-8

Identifiers

DOI

1 reference

2 December 2017

1 reference